Chen, Changlin
Wen, Di
Wang, Yizheng
Li, Hongqiong
Yu, Qi
Li, Mao
Funding for this research was provided by:
the project of Affiliated Hospital North Sichuan Medical College (Grant No.2022LC004.)
Article History
Received: 30 March 2022
Accepted: 21 June 2022
First Online: 2 July 2022
Declarations
:
: This randomized, double-blinded, prospective clinical trial study was registered with the Chinese registry of clinical trials atExternalRef removed(ChiCTR2100042847; May 12, 2021). The Research Ethics Committee of the Affiliated Hospital of North Sichuan Medical College approved the study (approval no. 2020ER201-1). This study adhered to the applicable CONSORT guidelines and was performed from February 2021 to December 2021. The first participant enrolled on February 4, 2021. Informed written consent was obtained from all participants. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.